检索结果 - Gabriele Elser

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial 由 Radoslav Chekerov, Felix Hilpert, Sven� Mahner, Ahmed El‐Balat, Philipp Harter, Nikolaus de Gregorio, C Fridrich, Susanne Markmann, Jochem Potenberg, Ralf Lorenz, Guelten Oskay-Oezcelik, Marcus Schmidt, Petra Krabisch, Hans-Joachim Lueck, Rolf Richter, Elena Ioana Braicu, Andreas du Bois, Jalid Sehouli, W. Lichtenegger, Isil Yalcinkaya, Marion Kittner, Ellen Konwert, Maren Keller, Alexander Mustea, D. Koensgen-Mustea, Klaus Pietzner, Oumar Camara, Pauline Wimberger, Gabriele Elser, Sandra Polleis

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

    Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1) 由 Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuß, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges, Guido Neidhardt, Nikolaus de Gregorio, Ahmed El‐Balat, Felix Hilpert, Werner Meier, Rainer Kimmig, Karin Kast, Jalid Sehouli, Klaus Baumann, Christian Jackisch, Tjoung‐Won Park‐Simon, Lars Hanker, Sandra Kröber, Jacobus Pfisterer, Heidrun Gevensleben, Andreas Schnelzer, Dimo Dietrich, Tanja Neunhöffer, Mathias Krockenberger, Sara Y. Brucker, Peter Nürnberg, Hölger Thiele, Janine Altmüller, Josefin Lamla, Gabriele Elser, Andreas du Bois, Eric Hahnen, Rita K. Schmutzler

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: